LFH-59803-69939
3 vaccinations
4 coded responses
40 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Anxiety — Feeling: Good · DiarrheaFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
- 2021-10-08
-
2021-11-02
Dose 2 — Moderna
- 2021-11-02
- 2021-11-03
-
2021-11-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2022-02-01
- 2022-05-03
-
2022-09-12
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-26
- 2022-10-03
- 2022-10-10
-
2022-10-17
Survey response — day 35, dose 3MedDRA: Throat irritation — Feeling: GoodFree text: Scratchy throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — day 42, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I got COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-25
-
2022-12-12
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I got COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-12
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-13
- 2022-12-13
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-02 | Moderna | No |
| 3 | 2022-09-12 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Anxiety
Release 12 — day 35, dose 3
Symptoms: Scratchy throat
Release 12 — day 42, dose 3
Symptoms: I got COVID
Release 12 — 3 months, dose 3
Symptoms: I got COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release